FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

19476911000001107: Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Sep 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65840201000001113 Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
76580601000001118 Rapilose 40% gel (Galen Ltd) 75 gram 3 x 25g tubes en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Is a Glucose 40% oral gel 75 gram true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Has AMP Rapilose 40% gel (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Has specific active ingredient Glucose true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Has dispensed dose form Conventional release oral gel false Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Has dispensed dose form Gel false Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Legal category Legal category not applicable true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Rapilose 40% gel (Aspire Pharma Ltd) 75 gram 3 x 25g tubes Has dispensed dose form Conventional release oral gel true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start